Arkolith/Insider Trading/ORTX/Form 4

Thomas Frank E

See RemarksOrchard Therapeutics plc (ORTX) · full profile →Form 4 · filed Oct 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
0 non-derivative · 16 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2022Grant(A)458K—$0458K
Oct 4, 2022Grant(A)75K—$075K
Oct 4, 2022Grant(A)28K—$028K
Oct 4, 2022Disposed to issuer(D)28K—$00
Oct 4, 2022Grant(A)310K—$0310K
Oct 4, 2022Disposed to issuer(D)310K—$00
Oct 4, 2022Grant(A)150K—$0150K
Oct 4, 2022Disposed to issuer(D)150K—$00
Oct 4, 2022Grant(A)200K—$0200K
Oct 4, 2022Disposed to issuer(D)200K—$00
Oct 4, 2022Disposed to issuer(D)426K—$00
Oct 4, 2022Grant(A)426K—$0426K
Oct 4, 2022Disposed to issuer(D)184K—$00
Oct 4, 2022Grant(A)184K—$0184K
Oct 4, 2022Disposed to issuer(D)100K—$00
Oct 4, 2022Grant(A)100K—$0100K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-053005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML